• Share

Obesogens: A unifying theory for the global rise in obesity

Food, nutrition and fresh water | Clinical impacts and solutions | Pollution, environmental and human health

A webinar recording from March 19th 2024

  • Date (DD-MM-YYYY)

    28-06-2024 to 28-01-2026

    Available on-demand until 28th January 2026

  • Cost

    Free

  • Education type

    Virtual

  • CPD subtype

    On-demand

Description

Download our Webinar Highlights fact sheet for key findings and quotes from this webinar.

Despite varied treatment, mitigation, and prevention efforts, the prevalence and severity of obesity continue to rise around the world. In this EDC Strategies Partnership webinar, Dr. Jerry Heindel presented a combined model of obesity causation that links four general models to create a unifying paradigm.

The four models include the energy balance model (EBM), based on calories as the driver of weight gain; the carbohydrate-insulin model (CIM), based on insulin as a driver of energy storage; the oxidation-reduction model (REDOX), based on reactive oxygen species (ROS) as a driver of altered metabolic signaling; and the obesogens model (OBS), which proposes that environmental chemicals interfere with hormonal signaling leading to adiposity.

Dr. Heindel presented a combined OBS/REDOX model in which environmental chemicals present in the air, food, food packaging, and household products generate false autocrine and endocrine metabolic signals. These signals then subvert standard mechanisms of energy regulation, increase basal and stimulated insulin secretion, disrupt energy efficiency, and influence appetite and energy expenditure leading to weight gain.

This combined model incorporates the data supporting the EBM and CIM models, thus creating one integrated model that covers significant aspects of all the mechanisms that are potentially contributing to the obesity pandemic. Importantly, the OBS/REDOX model provides a rationale and approach for future preventative efforts based on environmental chemical exposure reduction.

Coauthors Dr. Robert Lustig and Dr. Barbara Corkey joined for the Q&A portion of the discussion.

This webinar was moderated by Sharyle Patton, Director of Commonweal's Biomonitoring Resource Center.

Contact details